Although cervical cancer (CC) is a leading cause of cancerrelated deaths in developing countries, incidence rates vary considerably, ranging from 3 to 61 per 10 5 females. Identifying determinants of high vs. low rates may suggest population-level prevention strategies. CC rates for 175 countries were obtained from the IARC. Country-specific behavioral, health, economic and demographic measures were obtained from United Nations agencies and other international organizations. Regression analyses performed for 127 low or medium developed countries identified both geography and religion as independently associated with high CC rates. Among behavioral measures, high fertility rates, early age at birth of first child and high teenage birthrates were significantly associated with high CC rates. Countries with high CC rates had fewer doctors per capita, less immunization coverage, more HIV infections and shorter life expectancies. CC rates also tended to be higher in countries with more spending on health and younger, less educated populations. Patterns of CC rates suggest that programmatic approaches, such as promoting delayed childbearing and sexual monogamy, may be appropriate interventions.
Key words: cervical cancer; human papillomavirus; epidemiology; developing countries; ecologic analysis; sexual behaviorIn developing countries, cervical cancer (CC) ranks second to breast cancer in incidence 1 but represents the leading cause of cancer-related deaths among women. 2 Of the estimated 470,000 CC cases around the world each year, 380,000 (81%) occur in the developing world. 3 Several studies have conclusively determined that HPV plays an etiologic role in the development of invasive CC. 4 -6 Genital HPV is transmitted through sexual contact, 7 and estimates suggest that at least 50% of sexually active adults have had a genital HPV infection. 8 Currently, over 120 different HPV types have been identified, of which at least 38 primarily infect the genitalia. Four high-risk types ) account for about 80% of invasive CCs collected from around the world. 9 Among developed countries, CC incidence and mortality rates have markedly decreased through active screening and effective treatment. 10,11 However, national CC prevention programs are expensive and laborious and rely on delicate laboratory procedures. Screening programs have rarely been implemented and virtually never sustained in most developing countries. [12][13][14] Among the screening programs that have been introduced, many have had very poor quality and low coverage rates, with little financial support. 15,16 As a result, the less developed countries have CC mortality rates more than twice those of the developed countries with national CC prevention programs. 3 Relatively new screening methods, such as HPV DNA testing, now offer a viable alternative or adjunct to conventional Pap smears. 17,18 However, while these methods may prove feasible in a developed country's national screening program, they remain highly laboratory-dependent and are not yet applicable ...